Planning Financially for Multiple Sclerosis

Please enable cookies.

Error
1005

Ray ID: 83b6cea6ddac8af9 •
2023-12-26 05:08:40 UTC

What happened?

The owner of this website (www.webmd.com) has banned the autonomous system number (ASN) your IP address is in (47583) from accessing this website.

Was this page helpful?

Thank you for your feedback!

Cloudflare Ray ID: 83b6cea6ddac8af9

Your IP:

89.117.245.16


Performance & security by Cloudflare

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Oxford-AstraZeneca COVID-19 vaccine protection wanes after three months, study suggests thumbnail

Oxford-AstraZeneca COVID-19 vaccine protection wanes after three months, study suggests

Credit: Unsplash/CC0 Public Domain The protection offered by the Oxford-AstraZeneca COVID-19 vaccine declines after three months of receiving two doses, a study says. The findings—drawn from datasets in two countries—suggest that booster programs are needed to help maintain protection from severe disease in those vaccinated with Oxford-Astra Zeneca, experts say. Researchers from Scotland and Brazil…
Read More
Adding Darolutamide: New SOC for Metastatic Prostate Cancer thumbnail

Adding Darolutamide: New SOC for Metastatic Prostate Cancer

New data suggest that adding darolutamide (Nubeqa) onto androgen deprivation therapy (ADT) and docetaxel should become a new standard of care for men with metastatic hormone-sensitive prostate cancer (mHSPC), say investigators reporting results from the phase 3 ARASENS study. The three drug combination significantly reduced the risk of death by 32.5% (hazard ratio [HR], 0.68;…
Read More
New Guideline on Diagnosis, Treatment of Rare GI Syndromes thumbnail

New Guideline on Diagnosis, Treatment of Rare GI Syndromes

A clinical practice guideline for the diagnosis and management of gastrointestinal hamartomatous polyposis syndromes has just been published by the U.S. Multi-Society Task Force on Colorectal Cancer, which is comprised of experts representing the American College of Gastroenterology, the American Gastroenterological Association, and the American Society for Gastrointestinal Endoscopy. Gastrointestinal hamartomatous polyposis syndromes are rare,…
Read More
Index Of News
Total
0
Share